Journal of Oncological Research and Targeted Therapies

Dr Farid Khallouki

Ph.D.

  • Department: Department of Nutrition, Health and oncology
  • University: Moulay Ismail University
  • Country: Morocco

Prof. Farid Khallouki is a medicinal chemist and phytochemist with extensive expertise in natural product research. He obtained his Ph.D. from the Lorraine University of Metz, France, in 2003, and subsequently completed postdoctoral training at several leading institutions: DKFZ in Heidelberg, Germany (2003–2004), INSERM in Toulouse, France (2007–2009), and UAMS in Little Rock, Arkansas, USA (2009–2010). He later joined the Faculty of Science and Technology at the University Moulay Ismail in Morocco, where he holds a permanent academic position. Driven by a passion for discovering bioactive compounds from natural sources, Prof. Khallouki has contributed to numerous research projects and published in internationally recognized scientific journals. He is currently seeking collaborations with pharmaceutical companies and academic institutions in Morocco and abroad, with the aim of advancing research and innovation in the field of medicinal chemistry and natural products

Guest Editor and Topic Editor for leading journals

Associate/Editorial Board Member in several journals

Reviewer for international publishers including

Active member of international scientific networks

Invited and keynote speaker at major conferences

Supervised and co-supervised several Ph.D  

1. A comprehensive machine learning for high throughput Tuberculosis sequence analysis

2. Antiviral Potential of Cistus Ladanifer Extracts Against HSV-1 and SARS-CoV-2

3. Napthyridine-derived compounds as inhibitors for Staphylococcus aureus CrtM

4. Advances in phytosterol free forms and esters

5. Phytochemical analysis of Zingiber officinale essential oils

6. Vitamin D Status in the Drâa-Tafilalet Population

7. VitaminEome therapeutics: oxidation and cleavage products of tocols

8. Tamoxifen and Vitamin E in Breast Cancer Management

9. Bryonolic Acid inhibits cancer cell clonogenicity and invasiveness